Affinity Chromatography - Department of Molecular and Cellular ...
Affinity Chromatography - Department of Molecular and Cellular ...
Affinity Chromatography - Department of Molecular and Cellular ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Chapter 5<br />
Designing affinity media using pre-activated matrices<br />
Earlier chapters in this h<strong>and</strong>book have covered a wide range <strong>of</strong> lig<strong>and</strong>s that have been<br />
coupled to Sepharose to provide ready to use affinity media for specific groups <strong>of</strong> molecules.<br />
However, it is also possible to design new media for special purposes. When a ready to use<br />
affinity medium is not available, a medium can be designed for the purification <strong>of</strong> one or more<br />
target molecules by coupling a specific lig<strong>and</strong> onto a pre-activated chromatographic matrix.<br />
For example, antibodies, antigens, enzymes, receptors, small nucleic acids or peptides can<br />
be used as affinity lig<strong>and</strong>s to enable the purification <strong>of</strong> their corresponding binding partners.<br />
There are three key steps in the design <strong>of</strong> an affinity medium:<br />
• Choosing the matrix.<br />
• Choosing the lig<strong>and</strong> <strong>and</strong> spacer arm.<br />
• Choosing the coupling method.<br />
Choosing the matrix<br />
Sepharose provides a macroporous matrix with high chemical <strong>and</strong> physical stability <strong>and</strong><br />
low non-specific adsorption to facilitate a high binding capacity <strong>and</strong> sample recovery <strong>and</strong><br />
to ensure resistance to potentially harsh elution <strong>and</strong> wash conditions. The choice <strong>of</strong> a preactivated<br />
Sepharose matrix depends on the functional groups available on the lig<strong>and</strong> <strong>and</strong><br />
whether or not a spacer arm is required. Table 8 reviews the pre-activated matrices available.<br />
Choosing the lig<strong>and</strong> <strong>and</strong> spacer arm<br />
The lig<strong>and</strong> must selectively <strong>and</strong> reversibly interact with the target molecule(s) <strong>and</strong> must be<br />
compatible with the anticipated binding <strong>and</strong> elution conditions. The lig<strong>and</strong> must carry<br />
chemically modifiable functional groups through which it can be attached to the matrix<br />
without loss <strong>of</strong> activity (see Table 8).<br />
If possible, test the affinity <strong>of</strong> the lig<strong>and</strong>: target molecule interaction. Too low affinity will<br />
result in poor yields since the target protein may wash through or leak from the column<br />
during sample application. too high affinity will result in low yields since the target molecule<br />
may not dissociate from the lig<strong>and</strong> during elution.<br />
Use a lig<strong>and</strong> with the highest possible purity since the final purity <strong>of</strong> the target substance<br />
depends on the biospecific interaction.<br />
As discussed in Chapter 4, when using small lig<strong>and</strong>s (M r < 5 000) there is a risk <strong>of</strong> steric<br />
hindrance between the lig<strong>and</strong> <strong>and</strong> the matrix that restricts the binding <strong>of</strong> target molecules.<br />
In this case, select a pre-activated matrix with a spacer arm. For lig<strong>and</strong>s with M r > 5 000<br />
no spacer arm is necessary.<br />
Choosing the coupling method<br />
Lig<strong>and</strong>s are coupled via reactive functional groups such as amino, carboxyl, hydroxyl, thiol<br />
<strong>and</strong> aldehyde moieties. In the absence <strong>of</strong> information on the location <strong>of</strong> binding sites in the<br />
lig<strong>and</strong>, a systematic trial <strong>and</strong> error approach should be used.<br />
100